" class="no-js "lang="en-US"> Huma Archives - Medtech Alert
Wednesday, February 08, 2023

Sort by:

Date

Top Post

Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience

Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]

Huma Joins Forces With Independent Healthcare Provider to Launch Virtual Ward Service for the NHS

Huma are partnering with Xyla Elective Care, a national provider of NHS England-funded elective services, […]

Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care

Huma Therapeutics Limited, a global digital health technology company advancing digital-first care delivery and research […]

Huma Raises $130 Million Financing to Scale its Digital Health Platform for Better Care and Research

Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately […]

Huma and RARE-X Partner to Accelerate Research for 9,500 Rare Diseases

Huma, Europe’s fastest-growing health technology company, is partnering with the non-profit patient advocacy group RARE-X, which runs […]

  1. Tvardi Therapeutics Appoints John Kauh, M.D. as Chief Medical Officer Read more
  2. Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S. Read more
  3. Spectrum Science Receives Strategic Investment from Knox Lane to Fuel Continued Growth Read more
  4. Synergy Health Partners Selects Dr. Richard L. Makowiec as Chief Surgical Officer Read more
  5. TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials Read more